Target-Specific Selection
For a defined protein, review Protein Aptamer Selection. For a small molecule, compare Small-Molecule Aptamer Selection when target size, immobilization, or analog discrimination affects the design.
Creative Biolabs Technology
Creative Biolabs offers several SELEX platforms and selection strategies for aptamer discovery. The best option depends on the target format, how bound sequences can be separated, which interactions should be removed, and how much sequence information is needed. Our technology portfolio includes specialized SELEX platforms, Capture-SELEX, Counter-SELEX, Subtractive SELEX, Toggle SELEX, and high-throughput or computational approaches. These tools can be combined with related aptamer services when a project needs a tailored selection plan.
Choose the SELEX technology from the selection problem, not from the platform name alone. A small molecule, a membrane-associated target, and a cross-reactivity challenge need different target presentation and controls. Projects that need sequence-level monitoring may also benefit from high-throughput analysis across selection rounds.
We group SELEX technologies by the problem they solve. Specialized platforms mainly change how bound and unbound sequences are separated or measured. Selection strategies change which binders are kept or removed. High-throughput and computational methods help us compare and prioritize enriched sequence populations. These tools can be combined when the project needs more than one type of control or readout.
Capillary Electrophoresis-SELEX uses electrophoretic separation to distinguish target-bound nucleic-acid complexes from unbound sequences. Its main design value is the ability to make partitioning an analytical separation problem rather than relying only on repeated washing from a solid support. Fit depends on whether the target-bound and free populations can be resolved under suitable capillary conditions.
Microfluidic SELEX brings selection and partitioning into miniaturized fluidic formats. Microfluidic control can be useful when a project benefits from small reaction volumes, controlled transport, or integrated handling, but the device format must still match the target-presentation and recovery logic. Miniaturization does not remove the need for well-chosen controls or appropriate selection pressure.
AFM-SELEX incorporates atomic-force-microscopy principles into aptamer selection or interaction assessment. The technology is particularly relevant when force- or surface-based interaction information is central to the experimental concept. As with other platform variants, the value comes from how its physical measurement or partitioning mode addresses a specific target problem, not from treating it as a universal replacement for conventional SELEX.
Capture-SELEX reverses the usual immobilization logic by anchoring the nucleic-acid library and allowing target interaction to trigger release or another recoverable change. It is commonly discussed for small molecules that are difficult to immobilize without altering the recognition surface.
Counter-SELEX introduces defined non-targets so sequences recognizing unwanted molecules or shared features can be depleted. It is especially relevant when specificity against a close analog, related protein, cell type, or other known interferent is part of the selection objective.
Subtractive SELEX removes sequences that bind a related background or reference preparation. The concept is useful when the experimental question is defined by a difference between two otherwise similar contexts, such as a target-positive versus matched target-negative biological preparation.
Toggle SELEX alternates selection across related targets or target forms to enrich binders that retain recognition across those contexts. The approach is conceptually different from counter-selection: instead of rejecting one target, the selection intentionally preserves compatibility with more than one presentation.
High-throughput sequencing (HT-SELEX) can expand visibility into how sequence families change across selection rounds, revealing enrichment patterns that are not apparent from a small number of cloned endpoints. Computational analysis can then help organize large sequence sets by abundance, similarity, motif, predicted structure, or other project-defined features.
Computational aptamer design is an active research area that includes structure prediction, docking, machine-learning approaches, and sequence-generation models. These methods can be useful for hypothesis generation and candidate prioritization, but their predictive value depends on the quality of training data, the target representation, and the experimental system. For this reason, computational ranking should be treated as complementary to experimental selection and validation rather than as a substitute for binding evidence.
Soldevilla and colleagues used HT-SELEX to select RNA aptamers against recombinant LAG3-Fc. After seven selection rounds, pools from rounds 6 and 7 were analyzed by high-throughput sequencing. The authors grouped enriched sequence families, examined the most abundant candidates, and predicted their secondary structures before advancing selected aptamers to binding studies. The experiment also included counter-selection against IgG and progressively stronger selection conditions. This study shows the practical value of HT-SELEX when a project needs more than an endpoint sequence list: population structure, enrichment, and candidate relationships can be reviewed before individual clones are prioritized. It also shows an important limit. Sequencing did not replace experimental validation; the selected candidates were still tested for binding and specificity. For aptamer discovery, HT-SELEX is therefore most useful when sequence-level evidence needs to guide, rather than replace, downstream experimental decisions. 2
Start with the constraint that is hardest to solve. The same project may need one platform for partitioning and a separate strategy for specificity control, so the table below is a decision guide rather than a fixed recipe.
| Your main selection challenge | Technology to compare first | Why it may fit |
|---|---|---|
| Direct immobilization may hide or alter a small target | Capture-SELEX | Keeps the target free while the nucleic-acid library is captured, reducing dependence on direct target immobilization. |
| Bound and free species can be separated by mobility | Capillary Electrophoresis-SELEX | Turns partitioning into an analytical separation problem when target-bound and unbound populations can be resolved. |
| Small-volume handling or integrated processing matters | Microfluidic SELEX | Can combine controlled fluid handling with miniaturized selection steps when the device format matches the target and recovery logic. |
| Known interferents or matched background binders must be removed | Counter-SELEX or Subtractive SELEX | Adds explicit depletion pressure against a defined non-target or a related background preparation. |
| Binding should be retained across related target forms | Toggle SELEX | Alternates related targets so selection pressure favors recognition that survives across more than one target presentation. |
| Round-by-round sequence-family information is important | HT-SELEX & computational analysis | Adds deeper visibility into enrichment, diversity, clustering, and candidate prioritization while keeping experimental validation separate. |
If more than one row fits your project, continue to the Selection Path below. It separates target presentation, partitioning, selection pressure, and data planning so you can narrow the combination step by step.
Start with the target form, available material, desired specificity, and the research setting in which a useful aptamer must function.
Select a format that keeps the relevant target features accessible and makes bound-versus-unbound recovery experimentally defensible.
Introduce counter, subtractive, toggle, capture, or other strategy elements only when they solve a specific selection pressure or presentation problem.
Decide how enrichment will be monitored, how candidate diversity will be represented, and what evidence is needed before prioritization.
Evaluate selected candidates against the controls and research context that matter for the downstream use rather than relying on enrichment alone.
SELEX technology is one part of a wider aptamer discovery program. If you already know the target class, a target-specific service may be the fastest way to frame the project. If the route is still open, start with our aptamer discovery services and then match the selection technology to the target and research goal.
For a defined protein, review Protein Aptamer Selection. For a small molecule, compare Small-Molecule Aptamer Selection when target size, immobilization, or analog discrimination affects the design.
Use the specialized platforms and selection strategies on this page when target presentation, partitioning, counter-selection, or cross-target recognition changes the selection problem.
After candidate selection, Aptamer Characterization Services can address binding, specificity, structure, stability, and other agreed research questions before candidates move forward.
When lead sequences are defined, Aptamer Optimization Services can be considered for sequence-focused development before application-specific research.
No. A platform is useful when its partitioning or measurement principle fits the target and project constraints. The better choice depends on target presentation, separation behavior, specificity requirements, material limitations, and downstream evaluation.
A platform mainly changes how the selection is physically performed or how bound and unbound sequences are separated. A selection strategy changes which interactions are favored or depleted, for example through counter, subtractive, capture, or toggle logic.
Capture-SELEX is often considered when direct target immobilization is undesirable, especially for small molecules whose recognition surfaces may be altered by attaching them to a support.
Counter-SELEX usually uses defined unwanted targets to deplete cross-reactive sequences. Subtractive SELEX emphasizes removal of binders shared with a related background or reference preparation. In practice, the experimental designs can overlap, so the project question should define the terminology.
High-throughput sequencing can reveal sequence-family enrichment and diversity across rounds at a depth that endpoint cloning cannot. It improves visibility into the selected population, but candidate binding and specificity still require experimental assessment.
Not reliably in a general sense. Computational methods can help organize sequences, predict structures, generate hypotheses, or prioritize candidates, but their predictions depend on models and input data. Experimental selection and validation remain necessary for demonstrating binding behavior.